Key facts
- It has raised $5.1M across 3 recorded rounds; the latest was Seed Round ($952K) in Jan 2025.
- Notable investors include US National Science Foundation, Alabama Capital Network.
- AI Metrics has filed 2 Form Ds with the SEC since 2020, most recently Oct 2022 ($1.2M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AI Metrics
Funding rounds
3 roundsAbout AI Metrics
Developer of imaging software designed to assist radiologists in measuring and reporting cancer studies. The company offers AI-powered tools for tumor contouring, automatic anatomical labeling, and access to prior studies, enabling radiologists and oncologists to efficiently evaluate treatment response and streamline clinical trial assessments.
- Sector
- Healthcare
- HQ
- Birmingham, AL, United States
- Founded
- 2019
- Employees
- 13
- Website
- aimetrics.com/
- Ownership
- Privately Held (backing)
AI Metrics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AI Metrics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AI Metrics in its N-PORT filings yet. We sweep new filings monthly.